… Covidien (formerly United States Surgical, a division of Tyco Healthcare Group, L. P.) is conducting a FSCA of all production lots for the Duet TRS™ Universal Straight and Articulating Single Use Loading Units (SULU) with respect to the use of this product family in the thoracic cavity. Serious injuries and deaths have occurred due [...]
Tag Archives: age-related disease
Serious injuries and deaths have occurred due to the failure of a Tyco surgical stapler Duet TRS in the thoracic cavity
Wednesday, February 22, 2012
Filed in Ideas For Surgery News
|
Also tagged Accelerate Globalization, Accelerated investments, Access to capital, acquisition of technologies, acromis implementation and development, address patients’ need, address the high risk, adoption of austerity measures, advantageous position, adverse impact on technology, angel investors, around the globe, Asia, Attain the desired level of proficiency, availability of capital to fund future innovation, between adjacent vertebrae, biggest long-term opportunity, biomedical cluster, biomedical company CEOs, Biomedical industry, biotechnology, Candidates in queue, CE Mark trial, CEO, choosing the right delivery method, clinical value, Collaborative partnership, commercialize medtech, Compete on price, Competitive landscape, considered as a first line therapy, corporate partnerships as a source of financing, Corporate venture funding, cost-effective solutions, Coverage and reimbursement issues, dealing with high risk complications, declining procedure volume, Deliver value, delivering better economic value, Demonstrate the economic value, Develop specific plans to accelerate global growth, devices approved for procedures, Devices priced at hefty premium, diagnostics or medical equipment, Disease foundations, Disruptive business model, Diverse funding sources, DUET4535 Duet TRS™ 45 3.5MM STRAIGHT SULU, DUET4535A Duet TRS™ 45 3.5MM ARTICULATING SULU, DUET4548 Duet TRS™ 45 4.8MM STRAIGHT SULU, DUET4548A Duet TRS™ 45 4.8MM ARTICULATING SULU, DUET6035 Duet TRS™ 60 3.5MM STRAIGHT SULU. DUET6035A Duet TRS™ 60 3.5MM ARTICULATING SULU, DUET6048 Duet TRS™ 60 4.8MM STRAIGHT SULU. DUET6048A Duet TRS™ 60 4.8MM ARTICULATING SULU, Economic potential, engaging primarily with the physician, Enrollment in pilot study, Europe, European Market, Evaluated the merits of products, Evolving Market, Expanding insights into markets, FDA regulatory approval process, first mover advantage, First-in-man, focus on emerging markets, Germany, global growth goals, global leadership position, Global Markets, government grants, Growth opportunity, implants capable of being inserted trans-laterally, Implementation, Improve Execution, Improving ability to attract investment and grow, increased pressure in utilization, infringed patents, Infringement Verdict, innovation and state-of-the-art medical technology, innovative technologies, Investment of corporate funds into external endeavors, Japan, Japanese market, key opinion leader KOL, Leading biomedical region, less invasive treatment, licensing agreements, Look for other solutions, Maintain high standards of safety and effectiveness, Major emerging markets, Medical devices, Medtronic, meet the urgent need of patients, Meeting the needs, multinational, nascent technologies, necessity of the procedures to be performed in specialized centers, Next-generation, Non-governmental organizations NGO, noninvasive, nullify a patent, NuVasive, Optimize Innovation, OUS market, Outside The USA (OUS), overt risk, partnerships, pharmaceuticals, physicians’ learning curve, pivotal trial, plate and screw system, prevailing economic uncertainty, principle investigator, Prioritize investment, products in clinical development, progressive, proper selection of patients, Provider and payer levels, providing expertise. early clinical evidence, Raising money for a startup, recent launches, Recreate the ecosystem, Regulatory approval process in the world, Regulatory framework based on consistency, reimbursement pressure, restructuring initiatives, scheduled for completion, serial entrepreneur, slower growth of US markets, solutions that deliver better economic value, spinal fusion surgery, stabilize vertebrae in the cervical spine, Stakeholders, Standard of care, state-of-the-art procedure, sustainable growth, targeting a limited launch, tax incentives for innovation, Team work, threats to the biomedical industry’s growth, tissue retractor, Training of the physicians and staff, Uncertain regulatory environment, Under development, unfavorable reimbursement decision from the CMS, Unsuitable for open surgery, Venture Capital, Widespread rollout, Working collaboratively
|
Comments Off